Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 12 to 15, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Oct. 12 to 15, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
FDA Panel Recommends Approval of Johnson & Johnson Booster Shot
FRIDAY, Oct. 15, 2021 (HealthDay News) — In a unanimous vote, the U.S. Food and Drug Administration vaccine advisory panel on Friday recommended that the agency grant emergency use of booster shots of the Johnson & Johnson coronavirus vaccine.
Vaccinated Foreign Travelers Can Enter United States Beginning Nov. 8
FRIDAY, Oct. 15, 2021 (HealthDay News) — All international travelers who are fully vaccinated against the coronavirus will be able to enter the United States beginning Nov. 8, an official at the White House told The New York Times.
Incidence Rates of SARS-CoV-2 Similar for Children, Adults
FRIDAY, Oct. 15, 2021 (HealthDay News) — The incidence rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are similar for children and adults, but more infections among children are asymptomatic, according to a study published online Oct. 8 in JAMA Pediatrics.
Therapeutic-Dose LMWH Cuts Thromboembolism, Deaths in COVID-19
FRIDAY, Oct. 15, 2021 (HealthDay News) — For adult inpatients with COVID-19 who have elevated D-dimer levels, therapeutic-dose low-molecular-weight heparin (LMWH) reduces major thromboembolism and death compared with standard heparin thromboprophylaxis, according to a study published online Oct. 7 in JAMA Internal Medicine.
FDA Panel Supports Moderna Booster Shot for Older Adults, People at High Risk
THURSDAY, Oct. 14, 2021 (HealthDay News) — Mirroring a similar recommendation issued last month for the Pfizer COVID-19 vaccine, an expert advisory panel to the U.S. Food and Drug Administration on Thursday recommended a half-dose booster shot of the Moderna vaccine be given to certain recipients six months after their second shot.
Convalescent Plasma Unlikely to Improve Outcomes in Severe COVID-19
THURSDAY, Oct. 14, 2021 (HealthDay News) — Among critically ill adults with COVID-19, treatment with convalescent plasma had a low likelihood of improving the number of organ support-free days, according to a study published online Oct. 4 in the Journal of the American Medical Association.
Obesity May Up Length of Stay, Mortality for COVID-19 Patients in ICU
THURSDAY, Oct. 14, 2021 (HealthDay News) — A high body mass index (BMI) is associated with a higher risk for death and prolonged length of stay (LOS) in the intensive care unit (ICU) among patients with COVID-19, according to a study published online Oct. 13 in PLOS ONE.
Poor Oral Health Tied to Greater Severity of COVID-19
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths 
.jpeg)
